Dual-target weight-loss drug is 47% more effective than its rival | “Our study shows that treatment with tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference."

Dual-target weight-loss drug is 47% more effective than its rival | “Our study shows that treatment with tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference."

https://ift.tt/gJEF8xB via /r/tech https://ift.tt/xBELRC1

Comments